title: Low level of p27(Kip1) protein expression in gastric adenocarcinoma is associated with disease progression and poor outcome.
abstract: OBJECTIVE
  Low tumor expression of the p27(Kip1) protein, which is involved in cell cycle control and apoptosis, is considered a negative prognostic factor in different types of cancer. The aim of this study was to evaluate the clinical and pathological significance of low p27(Kip1) protein expression in patients who had undergone resection for gastric adenocarcinoma.
  
  
  METHODS
  p27(Kip1) protein was studied by immunohistochemistry in formalin-fixed tumor sections from 95 patients who underwent resection for gastric adenocarcinoma between 1991 and 1996. Based on the median value of protein expression, p27(Kip1) protein expression was classified as low or high.
  
  
  RESULTS
  Low p27(Kip1) protein expression was significantly associated with tumor de-differentiation, increased penetration through the gastric wall, lymph node metastasis, and advanced tumor stage. In the group of 84 patients who underwent curative surgery, 5-year survival was 74% in cases with high p27(Kip1) protein expression and 38% in those with low p27(Kip1) protein expression (P < 0.001). At multivariate analysis, low p27(Kip1) protein expression was an independent negative prognostic factor for survival (RR = 3.671; P = 0.004).
  
  
  CONCLUSIONS
  In gastric adenocarcinoma, low p27(Kip1) protein expression is associated with poorly differentiated and advanced tumors and is a negative prognostic factor of potential clinical value.
authors.affiliation: Department of Oncological and Surgical Sciences, University of Padova, Padova, Italy. donato.nitti@unipd.it
authors.forename: Donato
authors.initials: D
authors.lastname: Nitti
authors.forename: Claudio
authors.initials: C
authors.lastname: Belluco
authors.forename: Enzo
authors.initials: E
authors.lastname: Mammano
authors.forename: Alberto
authors.initials: A
authors.lastname: Marchet
authors.forename: Alessandro
authors.initials: A
authors.lastname: Ambrosi
authors.forename: Roberto
authors.initials: R
authors.lastname: Mencarelli
authors.forename: Paola
authors.initials: P
authors.lastname: Segato
authors.forename: Mario
authors.initials: M
authors.lastname: Lise
mesh_terms: D000230:Adenocarcinoma / Q000378:metabolism* / Q000473:pathology / Q000601:surgery; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D018797:Cell Cycle Proteins / Q000096:biosynthesis*; D050760:Cyclin-Dependent Kinase Inhibitor p27; D018450:Disease Progression; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D008297:Male; D008875:Middle Aged; D009361:Neoplasm Invasiveness; D011379:Prognosis; D013274:Stomach Neoplasms / Q000378:metabolism* / Q000473:pathology / Q000601:surgery; D016019:Survival Analysis; D016896:Treatment Outcome; D025521:Tumor Suppressor Proteins / Q000096:biosynthesis*
chemical_list: D018797:Cell Cycle Proteins; D025521:Tumor Suppressor Proteins; D050760:Cyclin-Dependent Kinase Inhibitor p27